Virbac India entered into Poultry Vaccine market with Innovative Genotype matched ND Vaccine in Collaboration with KBNP – Korean Bio-Technology
Virbac India have arranged multiple seminars with leading poultry consultant and key Poultry stake holders in Namakkal, Coimbatore, Hyderabad, Bangalore and Pune .
Virbac India associated with KBNP, a Korean Biological Company, and an expertise in biologicals. Launches specialized poultry vaccines to control the emerging NDV Genotype VII & XIII in poultry- which are creating havoc loss to poultry! Dalguban N+ (Live vaccine) & Himmvac ND Lasota (Live vaccine) for control of Newcastle Disease.
Grand launch seminar were held at Cities like Namakkal. Coimbatore, Hyderabad, Bangalore and Pune where eminent veterinarians, poultry industry stake holders and MD of many integrator companies participated. We had with us, Dr. Jeon as our chief speaker, to throw light on the Need of ND Vaccine of Genotype 7 in India & Mr. Kim Jeph Export Director of KBNP, Korea along with Virbac India Poultry Vaccine Team Dr. J.N.Saha & Dr. K. C. Sahoo .
Virbac Managing Director Mr. T Natesan was also present in Coimbatore and Namakkal to welcome all the participants. He welcomed the audience with a note that Virbac focus on poultry and poultry vaccines will be pivotal along with other segments. In future many more vaccines and products of Virbac will benefit the poultry.
Virbac India Senior VP Mr. Yogesh Garg, VPs Mr. Dilip Kumar Pune , Mr.R. Salar, RBM AK Velu/Siraj/ Venkat Reddy / Vijay Kumbhar have welcomed the guests and participants and happily hosted the participants along with Virbac ABM / Technical Executives/ Business Officers and Virbac Poultry Product Management team .
All Participants along with poultry consultants were very happy for such Virbac knowledge sharing seminar on Vaccine and also liked our innovative two vaccines Dalguban N+ (Live vaccine) & Himmvac ND Lasota (Live vaccine)